Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 620

1.

Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.

Rose JE, Behm FM, Ramsey C, Ritchie JC Jr.

Nicotine Tob Res. 2001 Nov;3(4):383-90.

PMID:
11694206
[PubMed - indexed for MEDLINE]
2.

Precessation treatment with nicotine skin patch facilitates smoking cessation.

Rose JE, Behm FM, Westman EC, Kukovich P.

Nicotine Tob Res. 2006 Feb;8(1):89-101.

PMID:
16497603
[PubMed - indexed for MEDLINE]
3.

Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.

Rose JE, Herskovic JE, Behm FM, Westman EC.

Nicotine Tob Res. 2009 Sep;11(9):1067-75. doi: 10.1093/ntr/ntp103. Epub 2009 Jun 30.

PMID:
19567826
[PubMed - indexed for MEDLINE]
4.

Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone.

Rose JE, Behm FM, Westman EC, Levin ED, Stein RM, Ripka GV.

Clin Pharmacol Ther. 1994 Jul;56(1):86-99.

PMID:
8033499
[PubMed - indexed for MEDLINE]
5.

Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?

Rezaishiraz H, Hyland A, Mahoney MC, O'Connor RJ, Cummings KM.

Nicotine Tob Res. 2007 Nov;9(11):1139-46.

PMID:
17978987
[PubMed - indexed for MEDLINE]
6.

Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments.

Rose JE, Behm FM.

Nicotine Tob Res. 2004 Jun;6(3):523-32.

PMID:
15203786
[PubMed - indexed for MEDLINE]
7.

Mecamylamine does not precipitate withdrawal in cigarette smokers.

Eissenberg T, Griffiths RR, Stitzer ML.

Psychopharmacology (Berl). 1996 Oct;127(4):328-36.

PMID:
8923568
[PubMed - indexed for MEDLINE]
8.

Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking.

Rose JE, Behm FM, Westman EC.

Pharmacol Biochem Behav. 2001 Feb;68(2):187-97.

PMID:
11267622
[PubMed - indexed for MEDLINE]
9.

New medications for nicotine dependence treatment.

Hurt RD.

Nicotine Tob Res. 1999;1 Suppl 2:S175-9; discussion S207-10. Review.

PMID:
11768177
[PubMed - indexed for MEDLINE]
10.

Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia.

Weinberger AH, Sacco KA, Creeden CL, Vessicchio JC, Jatlow PI, George TP.

Schizophr Res. 2007 Mar;91(1-3):217-25. Epub 2007 Feb 9.

PMID:
17293085
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.

Schuurmans MM, Diacon AH, van Biljon X, Bolliger CT.

Addiction. 2004 May;99(5):634-40.

PMID:
15078238
[PubMed - indexed for MEDLINE]
12.

Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.

Shiffman S.

Clin Ther. 2008 Aug;30(8):1461-75. doi: 10.1016/j.clinthera.2008.07.019.

PMID:
18803988
[PubMed - indexed for MEDLINE]
13.

A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers.

Berlin I, Saïd S, Spreux-Varoquaux O, Launay JM, Olivares R, Millet V, Lecrubier Y, Puech AJ.

Clin Pharmacol Ther. 1995 Oct;58(4):444-52.

PMID:
7586937
[PubMed - indexed for MEDLINE]
14.

Relationships between effects of smoking, gender, and alcohol dependence on platelet monoamine oxidase-B: activity, affinity labeling, and protein measurements.

Snell LD, Glanz J, Tabakoff B; WHO/ISBRA Study on State and Trait Markers ofAlcohol Use and Dependence Investigators.

Alcohol Clin Exp Res. 2002 Jul;26(7):1105-13.

PMID:
12170121
[PubMed - indexed for MEDLINE]
15.

Nicotine patch therapy in adolescent smokers.

Smith TA, House RF Jr, Croghan IT, Gauvin TR, Colligan RC, Offord KP, Gomez-Dahl LC, Hurt RD.

Pediatrics. 1996 Oct;98(4 Pt 1):659-67.

PMID:
8885942
[PubMed - indexed for MEDLINE]
16.

Platelet monoamine oxidase B activity changes across 31 days of smoking abstinence.

Gilbert DG, Zuo Y, Browning RA, Shaw TM, Rabinovich NE, Gilbert-Johnson AM, Plath L.

Nicotine Tob Res. 2003 Dec;5(6):813-9.

PMID:
14668065
[PubMed - indexed for MEDLINE]
17.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
[PubMed - indexed for MEDLINE]
18.

Increase in anger symptoms after smoking cessation predicts relapse.

Patterson F, Kerrin K, Wileyto EP, Lerman C.

Drug Alcohol Depend. 2008 May 1;95(1-2):173-6. doi: 10.1016/j.drugalcdep.2008.01.013. Epub 2008 Mar 6.

PMID:
18328642
[PubMed - indexed for MEDLINE]
19.

Nicotine dependence, withdrawal symptoms, and adolescents' readiness to quit smoking.

Prokhorov AV, Hudmon KS, de Moor CA, Kelder SH, Conroy JL, Ordway N.

Nicotine Tob Res. 2001 May;3(2):151-5.

PMID:
11403729
[PubMed - indexed for MEDLINE]
20.

Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy.

Rose JE, Behm FM, Westman EC.

Exp Clin Psychopharmacol. 1998 Aug;6(3):331-43.

PMID:
9725117
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk